Form 4: Teleflex Director Andrew Krakauer Receives Stock Options and Restricted Stock Units

Director Andrew Krakauer reports acquisition of stock options and restricted stock units in Teleflex Inc.

Summary

• On May 9, 2025, Andrew Krakauer, a director of Teleflex Inc. (TFX), reported transactions involving Teleflex common stock and stock options.
• Krakauer acquired 1,051 shares of common stock through a restricted stock unit award.
• He also acquired options to purchase 2,226 shares of common stock at an exercise price of $125.11, exercisable beginning May 9, 2026, and expiring on May 9, 2035.
• Following these transactions, Krakauer beneficially owns 6,192.0062 shares of Teleflex common stock and options to purchase 2,226 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard compensation practices and aligns director interests with shareholders. There are no indications of negative performance or concerns.

Positives

• The grant of restricted stock units and stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule of the restricted stock units includes a provision related to re-election, potentially incentivizing continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the equity grants suggest an expectation of continued contributions from the director.

Industry Context

Equity grants to directors are a common practice in publicly traded companies to align management's interests with those of shareholders. The specific terms of the grants, such as vesting schedules and exercise prices, can vary depending on company performance and industry standards.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across the medical device industry, with companies like Medtronic and Stryker also utilizing stock options and restricted stock units.
• Vesting schedules and option terms are generally comparable, often tied to continued service and company performance metrics.
• The specific number of shares and option grants would be benchmarked against companies of similar size and market capitalization within the medical technology sector.

Stakeholder Impact

• The equity grants align the director's interests with those of shareholders, potentially leading to decisions that benefit shareholder value.
• The grants do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Teleflex, Director, Krakauer, Stock Options, Restricted Stock Units, Beneficial Ownership, Form 4, TFX